StockUnited StatesNasdaqGM

ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

91.50USD

-2.8100 (-2.98%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 91.50

P/E—

Dvd Ind Yld—

P/B5.60

P/S—

Curr EV/T12M EBITDA-33.9

Mkt Cap (USD)6.2B

Curr EV (USD)5.3B

Per Share Data

EPS T12M-1.86

DPS—

Bk Val Per Sh18.20

Rev/Sh0.00

Cash/Sh13.19

Curr Shares Out66.2M

FCF/Sh-2.40

Cash Flow Analysis

P/CF-61.9

Curr P/FCF-61.7

CF/NI0.8

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate49.3%

Growth Potential

Dil EPS 1Y Gr46.4%

Cap 1Y Gr23.5%

BPS 1Y Gr-11.2%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr-1663.4%

Assets 1Y Gr23.4%

Profitability

EBITDA-0.2B

EBIT-0.2B

Operating Margin0.0%

Pretax Margin—

Net Margin0.0%

ROA-17.8%

ROE-18.2%

ROC-13.9%

Asset Turnover0.00

Structure

Current Ratio38.51

Quick Ratio38.03

Debt/Assets0.2%

Debt/Com Eq0.2%

Net Debt/EBITDA1.72

Tot Debt/Capital0.2%

Gross Margin0.0%

EBIT/Int Exp-123.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.